Juniper Biomedical

Worcester, United States Founded: 2019 • Age: 7 yrs
A neuromodulation platform is provided for pelvic health therapy.
Request Access

About Juniper Biomedical

Juniper Biomedical is a company based in Worcester (United States) founded in 2019 by Mario Romero Ortega and David N Constantine.. Juniper Biomedical has raised $2 million across 2 funding rounds from investors including NIH, Aatma Capital and Beacon Angels. Juniper Biomedical offers products and services including Neuromodulation Platform. Juniper Biomedical operates in a competitive market with competitors including Minze Health, INNOVO, Jude, Starling Medical and inContAlert, among others.

  • Headquarter Worcester, United States
  • Founders Mario Romero Ortega, David N Constantine
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Technology → Extended, Virtual & Augmented Reality
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1 M (USD), Grant

    May 10, 2024

  • Investors
    NIH

    & 4 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Juniper Biomedical

Juniper Biomedical offers a comprehensive portfolio of products and services, including Neuromodulation Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Implantable technology for treating pelvic health conditions.

Funding Insights of Juniper Biomedical

Juniper Biomedical has successfully raised a total of $2M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $1.0M
  • First Round

    (02 Apr 2024)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2024 Amount Grant - Juniper Biomedical Valuation

investors

NIH
Apr, 2024 Amount Seed - Juniper Biomedical Valuation Auroral Holdings
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Juniper Biomedical

Juniper Biomedical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Aatma Capital and Beacon Angels. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage investments are made in fast-growing startups by Beacon Angels.
Founded Year Domain Location
Angel Network for companies based in Boston
Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Juniper Biomedical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Juniper Biomedical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Juniper Biomedical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Juniper Biomedical

Juniper Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Minze Health, INNOVO, Jude, Starling Medical and inContAlert, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Diagnosis and monitoring solutions for voiding disorders are offered.
domain founded_year HQ Location
Women's urinary incontinence is managed by wearable pelvic floor trainers.
domain founded_year HQ Location
Jude is focused on bladder health and protection products.
domain founded_year HQ Location
AI-based platform is developed for urinary tract infection detection.
domain founded_year HQ Location
Wearable sensor and mobile app for bladder monitoring are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Juniper Biomedical

Frequently Asked Questions about Juniper Biomedical

When was Juniper Biomedical founded?

Juniper Biomedical was founded in 2019 and raised its 1st funding round 5 years after it was founded.

Where is Juniper Biomedical located?

Juniper Biomedical is headquartered in Worcester, United States. It is registered at Worcester, Massachusetts, United States.

Who is the current CEO of Juniper Biomedical?

David N Constantine is the current CEO of Juniper Biomedical. They have also founded this company.

Is Juniper Biomedical a funded company?

Juniper Biomedical is a funded company, having raised a total of $2M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Apr 02, 2024.

What does Juniper Biomedical do?

Juniper Biomedical was founded in 2019 in Worcester, United States, within the biomedical sector. A platform is operated to deliver therapy for pelvic health conditions through neuromodulation techniques. Normal neuromuscular function is restored in damaged pelvic floor tissue, while bladder activity is calmed. Treatment is focused on urinary incontinence, bowel incontinence, pelvic pain, sexual dysfunction, and related issues, with services accessible via the domain juniperbiomedical.com.

Who are the top competitors of Juniper Biomedical?

Juniper Biomedical's top competitors include Minze Health, INNOVO and Starling Medical.

What products or services does Juniper Biomedical offer?

Juniper Biomedical offers Neuromodulation Platform.

Who are Juniper Biomedical's investors?

Juniper Biomedical has 5 investors. Key investors include NIH, Aatma Capital, Beacon Angels, Hub Angels, and Auroral Holdings.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available